SCHEMBL23699386

SCHEMBL23699386

CN(CC(Cc1ccccc1F)C(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.47
CTSK P43235 1/20 0.47
RIPK1 Q13546 3/20 0.43
PTPN1 P18031 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SCN9A Q15858 5/20 0.37
GPR119 Q8TDV5 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23699429 0.84 CYP1A2 (0.51) ATMHTR2CSLC6A4
SCHEMBL23699405 0.82 MAOB (0.41) CTSSCTSKPTPN1SLC6A4
SCHEMBL16798442 0.81 CTSS (0.44) CTSSCTSKRIPK1PPARGPPARA
SCHEMBL30192155 0.81 CTSS (0.49) CTSSCTSKRIPK1PTPN1PPARG
SCHEMBL23699358 0.80 CTSS (0.47) CTSSCTSKRIPK1PPARGPPARA
SCHEMBL6320615 0.80 CTSS (0.48) CTSSCTSKRIPK1PTPN1PPARG
SCHEMBL25185778 0.80 CTSS (0.48) CTSSCTSKRIPK1PTPN1PPARG
SCHEMBL23699255 0.78 CTSK (0.44) CTSSCTSKPPARGHTR2CSLC6A4
SCHEMBL23719091 0.78 CTSK (0.44) CTSSCTSKPPARGHTR2CSLC6A4
SCHEMBL16798266 0.78 PPARA (0.40) PTPN1PPARGPPARAHTR2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed